Veracyte's top three insider shareholders as of September 17, 2026 are Marc Stapley (Chief Executive Officer, 432.07K shares), Rebecca Chambers (Chief Financial Officer, 166.03K shares), Phillip G. Febbo (Chief Scientific Med Officer, 133.05K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Marc Stapley | Chief Executive Officer | 432,073 | 0 | 432,073 | 27.0% | 04 Sep, 2026 |
| 2 | Rebecca Chambers | Chief Financial Officer | 166,025 | 0 | 166,025 | 10.4% | 04 Sep, 2026 |
| 3 | Phillip G. Febbo | Chief Scientific Med Officer | 133,048 | 0 | 133,048 | 8.3% | 04 Sep, 2026 |
| 4 | Annie Mcguire | Evp, General Counsel | 131,160 | 0 | 131,160 | 8.2% | 04 Sep, 2026 |
| 5 | John Leite | Global Chief Commercial Off | 128,344 | 0 | 128,344 | 8.0% | 04 Sep, 2026 |
| 6 | Tina Susan Nova | President, Clia U.S. | 76,988 | 0 | 76,988 | 4.8% | 07 Mar, 2022 |
| 7 | Giulia C Kennedy | Chief Scientific Med Officer | 65,970 | 0 | 65,970 | 4.1% | 08 Dec, 2022 |
| 8 | Robert S Epstein | Director | 57,718 | 0 | 57,718 | 3.6% | 15 Jun, 2026 |
| 9 | Eliav Barr | Director | 56,461 | 0 | 56,461 | 3.5% | 15 Jun, 2026 |
| 10 | Kevin Richard Haas | Chief Dev And Tech Officer | 44,221 | 0 | 44,221 | 2.8% | 14 Apr, 2026 |
| 11 | Jonathan Wygant | Vp, Chief Accounting Officer | 43,226 | 0 | 43,226 | 2.7% | 04 Sep, 2026 |
| 12 | Muna Bhanji | Director | 42,718 | 0 | 42,718 | 2.7% | 03 Sep, 2026 |
| 13 | Bonnie H Anderson | Executive Chairwoman | 41,377 | 0 | 41,377 | 2.6% | 06 Jun, 2023 |
| 14 | Evan/ Fa Jones | Director | 34,634 | 0 | 34,634 | 2.2% | 15 Jun, 2026 |
| 15 | John L Bishop | Director | 33,125 | 0 | 33,125 | 2.1% | 19 Jul, 2023 |
| 16 | Thomas F. Miller | Director | 31,100 | 0 | 31,100 | 1.9% | 15 Jun, 2026 |
| 17 | David Brent Shafer | Director | 31,100 | 0 | 31,100 | 1.9% | 15 Jun, 2026 |
| 18 | Jens Holstein | Director | 27,471 | 0 | 27,471 | 1.7% | 16 Sep, 2026 |
| 19 | Karin Eastham | Director | 15,097 | 0 | 15,097 | 0.9% | 22 Jun, 2026 |
| 20 | Kevin K Gordon | Director | 8,720 | 0 | 8,720 | 0.5% | 10 Jun, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Sep, 2026 | Annie Mcguire | Evp, General Counsel | Disposed F | 3,215 | $44.88 | $144.29K | 134,414 | Direct |
| 02 Sep, 2026 | Marc Stapley | Chief Executive Officer | Disposed F | 8,782 | $44.88 | $394.14K | 432,073 | Direct |
| 02 Sep, 2026 | Phillip G. Febbo | Chief Scientific Med Officer | Disposed F | 3,639 | $44.88 | $163.32K | 146,158 | Direct |
| 02 Sep, 2026 | Rebecca Chambers | Chief Financial Officer | Disposed F | 3,603 | $44.88 | $161.70K | 169,677 | Direct |
| 02 Sep, 2026 | Jonathan Wygant | Vp, Chief Accounting Officer | Disposed F | 1,361 | $44.88 | $61.08K | 43,226 | Direct |
| 02 Sep, 2026 | John Leite | Global Chief Commercial Off | Disposed F | 3,961 | $44.88 | $177.77K | 128,344 | Direct |
| 04 Sep, 2026 | Annie Mcguire | Evp, General Counsel | Disposed S | 2,154 | $42.79 | $92.17K | 132,260 | Direct |
| 04 Sep, 2026 | Phillip G. Febbo | Chief Scientific Med Officer | Disposed S | 10,405 | $42.89 | $446.30K | 135,753 | Direct |
| 04 Sep, 2026 | Rebecca Chambers | Chief Financial Officer | Disposed S | 2,477 | $42.81 | $106.03K | 167,200 | Direct |
| 04 Sep, 2026 | Phillip G. Febbo | Chief Scientific Med Officer | Disposed S | 2,705 | $43.66 | $118.11K | 133,048 | Direct |
| 04 Sep, 2026 | Annie Mcguire | Evp, General Counsel | Disposed S | 1,100 | $43.67 | $48.04K | 131,160 | Direct |
| 04 Sep, 2026 | Rebecca Chambers | Chief Financial Officer | Disposed S | 1,175 | $43.71 | $51.36K | 166,025 | Direct |
| 01 Sep, 2026 | Muna Bhanji | Director | Disposed S | 1,864 | $42.97 | $80.10K | 42,718 | Direct |
| 18 Jun, 2026 | Karin Eastham | Director | Disposed S | 3,200 | $52.78 | $168.91K | 15,626 | Direct |
| 18 Jun, 2026 | Karin Eastham | Director | Disposed S | 529 | $53.55 | $28.33K | 15,097 | Direct |
| 11 Jun, 2026 | Muna Bhanji | Director | Acquired A | 5,272 | $0.00 | $0 | 44,582 | Direct |
| 11 Jun, 2026 | Eliav Barr | Director | Acquired A | 5,272 | $0.00 | $0 | 56,461 | Direct |
| 11 Jun, 2026 | Jens Holstein | Director | Acquired A | 5,272 | $0.00 | $0 | 32,471 | Direct |
| 11 Jun, 2026 | Robert S Epstein | Director | Acquired A | 5,272 | $0.00 | $0 | 57,718 | Direct |
| 11 Jun, 2026 | Karin Eastham | Director | Acquired A | 5,272 | $0.00 | $0 | 18,826 | Direct |